Navigation Links
New PRO2000 HIV-Prevention Findings Important Milestone on Path Toward Development of Effective Vaginal Microbicide
Date:2/9/2009

dy.

To bolster these results additional trials must be run to generate confirming data. Fortunately, another study of PRO2000 (0.5 percent concentration) by the UK-based Microbicides Development Programme (MDP), a partnership of African and European researchers, is ongoing with results expected by the end of this year. The MDP study is taking place in South Africa, Tanzania, Uganda and Zambia.

Some important secondary data emerged from the HPTN 035 study. The study showed that HIV infection rates were the same in the placebo control arm and in the no gel arm, suggesting that women did not change their HIV risk behaviour when using a gel product, an important result that helps validate the safe introduction of microbicides into communities.

This trial and the others that have gone before it strengthen our resolve to continue with the important research needed to address the global AIDS epidemic. While IPM was not involved in the trial of PRO2000 and BufferGel, we strongly applaud and acknowledge with great respect the trial sponsors, researchers, staff and more than 3,000 study participants for their hard work, skill and commitment to improve women's health around the world.

This and other studies of early microbicide candidates in recent years have underscored the challenges we face in HIV prevention research and microbicide development. But they have also helped us map a path forward. The research community knows far more today about how to design and execute these complex clinical trials, and we are piloting novel trial designs with a sharper focus on participant adherence to increase the chance that the trial will generate the data needed for effective product development and licensure.

And as important as the PRO2000 data are in supporting the concept that a topical microbicide can prevent HIV infection, new products are needed that can increase the level of protection tha
'/>"/>

SOURCE The International Partnership for Microbicides
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. New Research Suggests Platelet Stickiness May be the Single Most Important Risk Factor in Patients Treated with Coronary Stents - Findings May be Applicable to Anyone with Vascular Disease
2. Dramatic JUPITER Findings Fail to Sway Prescribing Behavior, Poll Shows
3. Tibotec Presents Interim Findings for TMC435, an Investigational Genotype 1 Hepatitis C Treatment, at the AASLD Liver Meeting 2008
4. Nventa Presents Findings on Proprietary Toll-like Receptor 3 (TLR3) Agonist, Poly-ICR, at World Vaccine Congress
5. Prometheus Presents Findings From Development of PROMETHEUS(R) IBS Diagnostic, First Blood Test for IBS, at ACG Annual Scientific Meeting
6. New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohns Disease According to First-of-its Kind Study
7. More Findings on Gene Involved in Childhood Asthma
8. Interleukin Genetics to Present Important New Findings at 2008 World Congress on Osteoarthritis
9. VAI Findings Could Aid Diagnosis and Treatment of Several Types of Kidney Cancer
10. Findings on Bladder-Brain Link May Point to Better Treatments for Problems in Sleep, Attention
11. Halozyme Therapeutics Announces Positive Findings With Pegylated Enzyme in Prostate Cancer Models
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)...A, Md., Dec. 4 Northwest Biotherapeutics, Inc. ("... announced today that the US Patent and Trademark ...tem for automation of the initial stages of the ma... cancer vaccines. These initial manufacturing sta...ritic cells (which are the critical ingredient) in...
(Date:12/3/2009)...N, Mass., Dec. 3 Allen Medical Systems, a subsidi...ay announced the launch of its new Allen Amatech(T...website www.AllenAmatech.com . ,, The website ...d includes an online version of the new product ca...fications for the products. "We hope to make the n...
(Date:12/3/2009)...DOYLESTOWN, Pa., Dec. 3 Ted Karkus, Chairman and ...www.quigleyco.com announced today that the Compan...s to develop prescription pharmaceutical and OTC p...nterests to focus primarily on the OTC/Personal Ca...ted to its Cold-EEZE® and Kids-EEZE® bra...
Breaking Medicine Technology:Northwest Biotherapeutics Receives Approval of US Patent for Cost Saving Automation of High-Concentration DCVax(R) Manufacturing 2Northwest Biotherapeutics Receives Approval of US Patent for Cost Saving Automation of High-Concentration DCVax(R) Manufacturing 3Northwest Biotherapeutics Receives Approval of US Patent for Cost Saving Automation of High-Concentration DCVax(R) Manufacturing 4Northwest Biotherapeutics Receives Approval of US Patent for Cost Saving Automation of High-Concentration DCVax(R) Manufacturing 5Allen Medical Systems Announces the Launch of New Allen Amatech(TM) OEM Website 2Quigley CEO, Ted Karkus, Announces Phase One of 2010 Strategic Plan; Karkus Reports that the Primary Focus will be on Leveraging its OTC Platform; Company Aggressively Seeking Product Acquisitions and Line Extensions which Leverage its Distribution 2Quigley CEO, Ted Karkus, Announces Phase One of 2010 Strategic Plan; Karkus Reports that the Primary Focus will be on Leveraging its OTC Platform; Company Aggressively Seeking Product Acquisitions and Line Extensions which Leverage its Distribution 3Study finds adverse effects in treatment for primary sclerosing cholangitis 54858 1Study finds adverse effects in treatment for primary sclerosing cholangitis 54858 2Researchers boost production of biofuel that could replace gasoline 9616 1Researchers boost production of biofuel that could replace gasoline 9616 2Breeding their horns off a winner 9614 1Breeding their horns off a winner 9614 2
...term safety and efficacy of TAXUS drug- ...ATICK, Mass., and WASHINGTON, Oct. 22 Boston,Scie...ive-year and final,follow- up data from its TAXUS ...d at years one through four -- in patients who rec...ronary Stent compared to patients who,received a b...
...ed Safety, Consistently Positive Clinical ..., Oct. 22 Data presented today from,Abbott,s SPIR...ntinued,positive, statistically significant clinic... Coronary Stent System at one year, including cont...c events (MACE) and continued,non- inferior rates ...
Other Medicine Technology:Positive Five-Year Safety Data for TAXUS(R) Stent Reported in Boston Scientific Trial 2Positive Five-Year Safety Data for TAXUS(R) Stent Reported in Boston Scientific Trial 3Positive Five-Year Safety Data for TAXUS(R) Stent Reported in Boston Scientific Trial 4Abbott's XIENCE(TM) V Everolimus Eluting Coronary Stent Shows Continued Superiority to TAXUS Stent in Reducing Major Adverse Cardiac Events in SPIRIT III Clinical Trial 2Abbott's XIENCE(TM) V Everolimus Eluting Coronary Stent Shows Continued Superiority to TAXUS Stent in Reducing Major Adverse Cardiac Events in SPIRIT III Clinical Trial 3Abbott's XIENCE(TM) V Everolimus Eluting Coronary Stent Shows Continued Superiority to TAXUS Stent in Reducing Major Adverse Cardiac Events in SPIRIT III Clinical Trial 4Abbott's XIENCE(TM) V Everolimus Eluting Coronary Stent Shows Continued Superiority to TAXUS Stent in Reducing Major Adverse Cardiac Events in SPIRIT III Clinical Trial 5
(Date:12/5/2009)...day announced the launch of International Solution... insurance plan which follows the acclaimed modula...ring customers the flexibility to add or remove a ...ets, International Solutions enables customers to ...offered in their country of residence. , ...
(Date:12/5/2009)...bines are popping up in the most unusual places, a... wine to keeping prisoners in jail! , ... have thought that your wine, water and vegetables...Fort Worth, Texas has announced a new line of turb...ing a technology developed to provide power for da...
(Date:12/4/2009)...tment Trust Inc. (NYSE: CRE ) ("Care" or the "C...rs has declared a dividend of $0.17 per share of c...22, 2009 to common shareholders of record on Decem...,, Care Investment Trust Inc. is a real estate inv...e-related real estate and commercial mortgage debt...
(Date:12/4/2009)...rive, Inc. has won the Patient,s Choice Award as t...ar vote conducted by the online website, www.weed... the SF Bay community has selected Medithrive as t...ijuana. ,, The rapid rise and popularity of Medi...ters to the consumer, provides a beautiful environ...
(Date:12/4/2009)...can Association of Homes and Services for the Agin...he Community Living and Supportive Services (CLASS...islation . The CLASS provisions are essential for ...ies and their caregivers. ,, We urge the Senate t... affordable to care for families and caregivers. ,...
Breaking Medicine News(10 mins):Health News:AVIVA's Private Health Insurance Products Solutions Go International 2Health News:Distributor Announces New Applications for Wind Turbines 2Health News:Distributor Announces New Applications for Wind Turbines 3Health News:Care Investment Trust Inc. Declares Quarterly Dividend of $0.17 Per Share 2
...nal Toxicology Program (NTP), has produced strong ... chromium (chromium 6) causes cancer when it is c...omium compounds are often used in electroplating, ...veloped malignant tumors upon administration of th...
...low-dose tablet of aspirin daily to prevent blood ...cations such as pre-eclampsia. The review,...ound that taking aspirin had a 10 percent reduced ... aspirin appears to slightly increase the risk of ...
... today approved a proposed campaign to raise at le...st phase of UCSF Medical Center at Mission Bay. ...ated medical center to serve children, women and c... in 2014, the 865,000-plus-gross-square-foot hospi...
...tically monitored because not enough is known abou... group of scientists writing in todays British Med...ed foods which claim to improve health, quality of...g in popularity. Between January and April 2005 20...
...ever Limited (HLL) in Kodaikanal, a popular hill s..., traveled all the way to Bombay in western India ...ompanys share-holders to raise to raise the issues...nently its controversial thermometer plant at Koda...
...the California Department of Insurance and the Ora... fraud. These three are being accused of perf...ently billing more than $30 million to insurance c...ate insurance fraud scheme in which hundreds of pa...
Other Medicine News:Health News:UC Regents Approve Fundraised Campaign for UCSF Medical Center at Mission Bay 2Health News:Functional Foods Must Be Monitored to Assess Their Long-term Safety and Effectiveness 2Health News:Poisoned Workers of Hindustan Lever Demand Treatment 2Health News:Poisoned Workers of Hindustan Lever Demand Treatment 3Health News:Poisoned Workers of Hindustan Lever Demand Treatment 4Health News:Rent-A Body Scam Busted 2Health News:Rent-A Body Scam Busted 3
Sterile Individually Packed 100 mL Solution Basins
Serological Pipettes - 2 ml from TPP
...measuring pipettes, enables you to pipette safely,... with all types of glass or plastic pipettes in th... Aid is equipped with a safety valve and replaceab...f the device from contamination by the vapors of s...
Finnpipette BioMate Pipette Aid
Medicine Products: